Why partner with Venn’s Pharmacokinetics Team? Venn Life Sciences contributes to International Partnership for Microbicides (IPM) clinical pharmacology program by providing a diverse range of services (e.g. consultancy, non-compartmental pharmacokinetic… read more →
Venn Life Sciences Holdings Plc (“Venn” or the “Company”) Interim Results for 6 months ended 30 June 2018 Venn Life Sciences (“Venn”) an Integrated Drug Development Partner offering a combination… read more →
This video from the Ernst & Young Entrepreneur of the Year Program 2018 is a little insight into our business and of course our CEO! Click here for the full… read more →
20 July 2018 Venn Life Sciences Holdings plc (“Venn” or the “Company” or the “Group”) Result of General Meeting Venn Life Sciences Holdings plc, an Integrated Drug Development Partner offering… read more →
Having assumed the role of chief executive of Venn Life Sciences in 2010, Tony Richardson quickly set about expanding the company, completing two acquisitions that year, which provided the basis… read more →